USANA Health Sciences Reports Second Quarter 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
USANA Health Sciences (USNA) Misses Q2 EPS by 2c, Offers FY Guidance
July 23, 2019 4:20 PM EDTUSANA Health Sciences (NYSE: USNA) reported Q2 EPS of $0.91, $0.02 worse than the analyst estimate of $0.93. Revenue for the quarter came in at $256 million versus the consensus estimate of $254.58 million.
GUIDANCE:
USANA Health Sciences sees FY2019 EPS of $3.70-$4.10, versus the... More
